ABBVIE: To create a Hep C cure that truly challenges treatment limitations—like DDIs, reduced efficacy in those taking PPIs, or inability to treat people with severe renal impairment—we looked deeply at patients. Through them, we understood why previous treatments had failed, and we discovered one Hep C answer, for everyone. Introducing EndGen: Finally, your cure is here.
